Do you want to read an article? Please log in or register.
Biomarker-Based Risk Prediction With The ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation
Atrial Fibrillation
Related content
Atrial Fibrillation
Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48
Circulation.
Berg DD, Ruff CT, Jarolim P, Giugliano RP, Nordio F, Lanz HJ, Mercuri MF, Antman EM, Braunwald E, Morrow DA
doi: 10.1161/CIRCULATIONAHA.
Atrial Fibrillation
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation
J Am Coll Cardiol.
Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, Poloczek M, Stasek J, Haman L, Branny M, Chovancik J, Cervinka P, Holy J, Kovarnik T, Zemanek D, Havranek S, Vancura V, Opatrny J, Peichl P, Tousek P, Lekesova V, Jarkovsky J, Novackova M, Benesova K, Widimsky P, Reddy VY, PRAGUE-17 Trial Investigators.
doi: 10.1016/j.jacc.2020.04.067.
Atrial Fibrillation
Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT)
Eur Heart J.
Piazza G, Hurwitz S, Galvin CE, Harrigan L, Baklla S, Hohlfelder B, Carroll B, Landman AB, Emani S, Goldhaber SZ
doi: 10.1093/eurheartj/ehz385.
Atrial FibrillationThrombosis and StrokeTherapy and Intervention
Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation
JAMA Cardiol.
Butt JH, Xian Y, Peterson ED, Olsen PS, Rørth R, Gundlund A, Olesen JB, Gislason GH, Torp-Pedersen C, Køber L, Fosbøl EL
doi: 10.1001/jamacardio.
Atrial FibrillationHeart Failure
Risk model for predicting complications in patients undergoing atrial fibrillation ablation
Heart Rhythm.
Padala SK, Gunda S, Sharma PS, Kang L, Koneru JN, Ellenbogen KA
doi: 10.1016/j.hrthm.2017.04.042.
Atrial Fibrillation
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial
J Am Heart Assoc.
Pol T, Held C, Westerbergh J, Lindbäck J, Alexander JH, Alings M, Erol C, Goto S, Halvorsen S, Huber K, Hanna M, Lopes RD, Ruzyllo W, Granger CB, Hijazi Z
doi: 10.1161/JAHA.117.007444.
COMMENTED
Atrial Fibrillation
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants
★ 2
Recommended and commented by
Prof. Dr Sacha P. Salzberg, Faculty Member
J Am Coll Cardiol
Camm AJ, Cools F, Virdone S, Bassand JP, Fitzmaurice DA, Arthur Fox KA, Goldhaber SZ, Goto S, Haas S, Mantovani LG, Kayani G, Grierson Turpie AG, Antoon Verheugt FW, Kakkar AK, GARFIELD-AF Investigators.
doi: 10.1016/j.jacc.2020.07.045
Atrial FibrillationThrombosis and Stroke
Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk
Heart.
Verbrugge FH, Martin AC, Siegal D, Pieper K, Illingworth L, Camm AJ, Fox KAA
doi: 10.1136/heartjnl-2019-315873.
Atrial FibrillationHeart Failure
The Use of Biomarkers to Predict Specific Causes of Death in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial
Circulation.
Sharma A, Hijazi Z, Andersson U, Al-Khatib SM, Lopes RD, Alexander JH, Held C, Hylek EM, Leonardi S, Hanna M, Ezekowitz JA, Siegbahn A, Granger CB, Wallentin L
doi: 10.1161/